Stroke Trial, Recruiting NCT06107010 Sponsor: Wandercraft Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06107010
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are over 18 years old
  • You have had your first stroke that caused a significant physical disability
  • You have weakness or partial paralysis on one side of your body (due to stroke) and are between 1 and 4 months from when the stroke happened
  • You have significant difficulty walking, scoring below 2 on a walking ability scale (meaning you need a lot of support or cannot walk independently)
  • You have health insurance
  • You are willing and able to give your informed consent to take part; if a physical disability makes signing difficult, an impartial witness may sign on your behalf

Who may not be able to join:

  • You have muscle stiffness or spasms in the hip, thigh, or foot muscles that would interfere with wearing a robotic exoskeleton, based on the doctor's judgment
  • You have had a bone fracture in the last 3 months, or you are taking treatment that weakens your bones
  • You have severe joint pain in your legs that would interfere with participation, based on the doctor's judgment
  • You have any skin sore or pressure wound (even mild) on areas that would be in contact with the exoskeleton device
  • You have a medical condition that prevents you from doing moderate physical activity
  • You experience a significant drop in blood pressure when standing up (confirm with trial site)
  • You have seizures that are not well controlled by medication
  • Your body shape or size does not fit the exoskeleton device as described in its manual (confirm with trial site)
  • You are pregnant
  • You are not able to give informed consent yourself, or you are currently held in a prison or other place of detention
  • You are currently taking part in another clinical trial involving a treatment or intervention

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Wandercraft
Registry
ClinicalTrials.gov
Start date
12 June 2023
Est. completion
28 February 2026

Where this trial is recruiting

🇫🇷 France 🇩🇪 Germany 🇪🇸 Spain

Primary endpoints

Walking recovery expressed by the proportion of patients reaching a Functional Ambulation Category (FAC) score of 4 or higher at the end of the intervention period, assessed without the exoskeleton.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov